6-methyl-N-(1H-tetrazol-5-yl)-2-pyridinecarboxamide | 83282-08-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 6-methyl-N-(1H-tetrazol-5-yl)-2-pyridinecarboxamide
• 英文别名: N-(1H-tetrazol-5-yl)-6-methyl-2-pyridinecarboxamide；TA-5707F；N-(5-tetrazolyl)-6-methyl-2-pyridinecarboxamide；6-methyl-N-(2H-tetrazol-5-yl)pyridine-2-carboxamide
• CAS: 83282-08-0
• 化学式: C₈H₈N₆O
• mdl: MFCD01692209
• 分子量: 204.191
• InChiKey: UQHAIRDRZJDIBZ-UHFFFAOYSA-N

物化性质

• 密度：
  1.503±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  96.4
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  6-methyl-N-(1H-tetrazol-5-yl)-2-pyridinecarboxamide 生成 N-(Tetrazol-5-yl)-6-methylpyridine-2-carboxamide monosodium salt
  参考文献：
  名称：

  TAKEDA, MIKIO;HONMA, YASUSHI;TSUZURAHARA, KEI

  摘要：

  DOI：
• 作为产物：
  描述：

  6-甲基吡啶-2-羧酸盐酸盐 在 氯化亚砜 、 三乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 4.0h， 生成 6-methyl-N-(1H-tetrazol-5-yl)-2-pyridinecarboxamide
  参考文献：
  名称：

  Antiallergic agents. 3. N-(1H-tetrazol-5-yl)-2-pyridinecarboxamides

  摘要：

  A series of N-tetrazolylpyridinecarboxamides was prepared and evaluated for antiallergic activity by the passive cutaneous anaphylaxis (PCA) assay. From the structure-activity relationships (SAR) of this class of compounds, it was revealed that the N-tetrazolylcarbamoyl group as an acidic functionality is required to be at the 2-position of the pyridine nucleus and that the phenyl group as a subtituent is not necessarily required for activity. 6-Methyl-N-(1H-tetrazol-5-yl)-2-pyridinecarboxamide (36) showed good oral activity and low toxicity.

  DOI：

  10.1021/jm00368a005

文献信息

• 2-Pyridinecarboxamide derivatives compositions containing same and
  申请人：Tanabe Seiyaku Co., Ltd.

  公开号：US04404214A1

  公开（公告）日：1983-09-13

  A 2-pyridinecarboxamide derivative of the formula: ##STR1## wherein R.sup.1 is hydrogen, lower alkyl, lower alkoxy, halogen, lower alkyl-thio or nitro and is in the 3rd-, 4th- or 5th-position of the pyridyl group, and R.sup.2 is hydrogen, lower alkyl, lower alkoxy, phenoxy, phenyl-lower alkyl, phenyl-lower alkenyl, or halogen. Said 2-pyridinecarboxamide derivative (I) or a pharmaceutically acceptable salt thereof is useful as an anti-allergic agent.

  该2-吡啶羧酰胺衍生物的化学式为：##STR1## 其中R.sup.1为氢、较低的烷基、较低的烷氧基、卤素、较低的烷基硫或硝基，并位于吡啶基的第3、第4或第5位置，而R.sup.2为氢、较低的烷基、较低的烷氧基、苯氧基、苯基-较低的烷基、苯基-较低的烯基或卤素。所述的2-吡啶羧酰胺衍生物(I)或其药用可接受的盐可用作抗过敏药物。
• Tetrazole amide derivatives of heterocyclic alkenyl acids and their use as antiallergic substances
  申请人：VALEAS S.p.A. INDUSTRIA CHIMICA E FARMACEUTICA

  公开号：EP0384450A1

  公开（公告）日：1990-08-29

  Tetrazole amide derivatives of heterocyclic alkenyl acids, of general formula (I): in which Y = NH, O or S when m = 1; Y = N when m = 2; m = 1 or 2; l = 0 or 4; R = H, C₁₋₄ alkyl, Cl, Br, CF₃, CH₂OCOCH₃, or OCH₂-Ph; R₁ = H, alkaline metal or alkaline earth metal; the double bond of the alkenyl chain being of trans or cis configuration and the possible benzene ring being unsubstituted or substituted. Said derivatives possess high antiallergic activity.

  杂环烯烃酸的四唑酰胺衍生物，一般式（I）如下：其中Y = NH、O或S，当m = 1 时；Y = N，当m = 2 时；m = 1 或 2；l = 0 或 4；R = H、C₁₋₄烷基、Cl、Br、CF₃、CH₂OCOCH₃或OCH₂-Ph；R₁ = H、碱金属或碱土金属；烯烃链的双键为顺式或反式构型，可能的苯环未取代或取代。这些衍生物具有很高的抗过敏活性。
• 2-Pyridinecarboxamide derivative, process for preparing same and pharmaceutical composition, useful as an anti-allergic agent
  申请人：Tanabe Seiyaku Co., Ltd.

  公开号：EP0053789A1

  公开（公告）日：1982-06-16

  A 2-pyridinecarboxamide derivative of the formula: wherein R' is hydrogen, lower alkyl, lower alkoxy, halogen, lower alkyl-thio or nitro and is in the 3rd-, 4th- or 5th- position of the pyridyl group, and R2 is hydrogen, lower alkyl, lower alkoxy, phenoxy, phenyl-lower alkyl, phenyl-lower alkenyl, or halogen. Said 2-pyridinecarboxamide derivative (I) or a pharmaceutically acceptable salt thereof is useful as an anti-allergic agent.

  式中的 2-吡啶甲酰胺衍生物： 其中 R' 为氢、低级烷基、低级烷氧基、卤素、低级烷硫基或硝基，且位于吡啶基的第 3 位、第 4 位或第 5 位；R2 为氢、低级烷基、低级烷氧基、苯氧基、苯基-低级烷基、苯基-低级烯基或卤素。所述 2-吡啶甲酰胺衍生物（I）或其药学上可接受的盐可用作抗过敏剂。
• Pyrazine derivative, a process for preparation thereof and pharmaceutical composition therefrom
  申请人：Hokuriku Pharmaceutical Co.,Ltd

  公开号：EP0227026A1

  公开（公告）日：1987-07-01

  Novel pyrazine derivatives useful for treatment of bronchial asthma, allergic gastroenteric trouble, hay fever urticaria, allergic rhinitis, allergic conjunctivitis are disclosed.

  公开了可用于治疗支气管哮喘、过敏性肠胃病、花粉热荨麻疹、过敏性鼻炎和过敏性结膜炎的新型吡嗪衍生物。
• Compositions of antiallergics and antihistamines and methods for their use
  申请人：ALCON LABORATORIES, INC.

  公开号：EP0433766A1

  公开（公告）日：1991-06-26

  Compositions of an antiallergic compound and an antihistamine for preventing and treating ophthalmic allergic response are disclosed. Methods for preventing and treating ophthalmic allergic response with the compositions are also disclosed.

  本发明公开了用于预防和治疗眼科过敏反应的抗过敏化合物和抗组胺剂的组合物。还公开了使用该组合物预防和治疗眼科过敏反应的方法。